Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis.
A patient with end-stage cirrhosis complicating HBsAg-positive chronic active hepatitis given a heterotopic liver transplant is alive and well 28 months after transplantation; liver function is normal, and there are no hepatitis-B related lesions on the liver graft despite positivity of HBsAg in the serum. This observation confirms that a heterotopic liver graft can offer long-term survival in man and suggests that this technique may be a more suitable procedure than orthotopic transplantation in end-stage cirrhotics.
D002675:Child, Preschool; D003135:Common Bile Duct / Q000601:surgery; D005500:Follow-Up Studies; D005704:Gallbladder / Q000601:surgery; D006499:Hepatic Artery / Q000601:surgery; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D007583:Jejunum / Q000601:surgery; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology; D008103:Liver Cirrhosis / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D008722:Methods; D008875:Middle Aged; D011169:Portal Vein / Q000601:surgery; D011877:Radionuclide Imaging; D013997:Time Factors; D014184:Transplantation, Homologous; D014682:Vena Cava, Inferior / Q000601:surgery